Stereotaxis Inc Stock price OTC Bulletin Board
Equities
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | 0.00% |
Mar. 04 | Transcript : Stereotaxis, Inc., Q4 2023 Earnings Call, Mar 04, 2024 | |
Mar. 04 | Earnings Flash (STXS) STEREOTAXIS Reports Q4 Revenue $4.6M, vs. Street Est of $7.7M | MT |
Financials (USD)
Sales 2024 * | 30.6M | Sales 2025 * | 43.54M | Capitalization | 188M |
---|---|---|---|---|---|
Net income 2024 * | -19M | Net income 2025 * | -14M | EV / Sales 2024 * | 6.16 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 4.33 x |
P/E ratio 2024 * |
-11.4
x | P/E ratio 2025 * |
-15
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.92% |
Latest transcript on Stereotaxis Inc
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 16-09-28 | |
Director of Finance/CFO | 55 | 02-12-31 | |
Laura Garth
LAW | General Counsel | - | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Messey
BRD | Director/Board Member | 78 | 05-04-30 |
Chief Executive Officer | 57 | 16-09-28 | |
Nathan Fischel
BRD | Director/Board Member | 68 | 17-02-02 |
1st Jan change | Capi. | |
---|---|---|
+9.50% | 221B | |
+7.95% | 184B | |
+18.30% | 142B | |
+18.47% | 101B | |
+7.83% | 68.07B | |
+25.32% | 57.27B | |
-3.69% | 47.42B | |
+4.66% | 43.19B | |
+15.12% | 28.84B |
- Stock
- Equities
- Stock Stereotaxis, Inc.
- Stock Stereotaxis Inc - OTC Bulletin Board